CIK 0001446847
- Accelerated filer
- Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043404176
- Phone
- +1 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-02 | Shetzline Michael CMO,SVP,Head-Res&Drug | Grant or award | +81,448 | 276,828 | ||
| 2022-02-28 | Silver Ronald Principal Accounting Officer | Sale | −448 | $10.77 | $5K | 63,001 |
| 2022-02-28 | Silver Ronald Principal Accounting Officer | Sale | −640 | $10.77 | $7K | 62,361 |
| 2022-02-28 | Silver Ronald Principal Accounting Officer | Sale | −1,150 | $10.77 | $12K | 61,211 |
| 2022-02-28 | MCCOURT Thomas A Chief Executive Officer | Sale | −1,942 | $10.77 | $21K | 632,802 |
| 2022-02-28 | MCCOURT Thomas A Chief Executive Officer | Sale | −10,026 | $10.77 | $108K | 622,776 |
| 2022-02-28 | MCCOURT Thomas A Chief Executive Officer | Sale | −19,970 | $10.77 | $215K | 602,806 |
| 2022-02-28 | MCCOURT Thomas A Chief Executive Officer | Sale | −16,486 | $10.77 | $178K | 586,320 |
| 2022-02-28 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −1,367 | $10.77 | $15K | 211,620 |
| 2022-02-28 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −2,911 | $10.77 | $31K | 208,709 |
| 2022-02-28 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −5,161 | $10.77 | $56K | 203,548 |
| 2022-02-28 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −3,804 | $10.77 | $41K | 199,744 |
| 2022-02-28 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −4,364 | $10.77 | $47K | 195,380 |
| 2022-02-28 | Rickard Jason SVP, Chief Operating Officer | Sale | −1,913 | $10.77 | $21K | 354,162 |
| 2022-02-28 | Rickard Jason SVP, Chief Operating Officer | Sale | −3,150 | $10.77 | $34K | 351,012 |
| 2022-02-28 | Rickard Jason SVP, Chief Operating Officer | Sale | −6,022 | $10.77 | $65K | 344,990 |
| 2022-02-28 | Rickard Jason SVP, Chief Operating Officer | Sale | −11,057 | $10.77 | $119K | 333,933 |
| 2022-02-28 | Rickard Jason SVP, Chief Operating Officer | Sale | −6,820 | $10.77 | $73K | 327,113 |
| 2022-01-19 | Shetzline Michael CMO,SVP,Head-Res&Drug | Grant or award | +29,326 | 212,987 | ||
| 2022-01-19 | Rickard Jason SVP, Chief Operating Officer | Grant or award | +36,174 | 356,075 |
Page 13 of 14 · 274 trades